Cannabinoid receptor 1 is a major mediator of renal fibrosis

Bascands, 2005, Obstructive nephropathy: insights from genetically engineered animals, Kidney Int, 68, 925, 10.1111/j.1523-1755.2005.00486.x

Dol-Gleizes, 2008, Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice, Arterioscler Thromb Vasc Biol, 29, 12, 10.1161/ATVBAHA.108.168757

Janiak, 2007, Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats, Kidney Int, 72, 1345, 10.1038/sj.ki.5002540

Deutsch, 1997, Production and physiological actions of anandamide in the vasculature of the rat kidney, J Clin Invest, 100, 1538, 10.1172/JCI119677

Barutta, 2010, Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy, Diabetes, 59, 1046, 10.2337/db09-1336

Julien, 2005, Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, 128, 742, 10.1053/j.gastro.2004.12.050

Boor, 2012, The renal (myo-)fibroblast: a heterogeneous group of cells, Nephrol Dial Transplant, 27, 3027, 10.1093/ndt/gfs296

Mesnard, 2009, Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis, J Am Soc Nephrol, 20, 1282, 10.1681/ASN.2008040433

Bascands, 2005, Obstructive nephropathy: insights from genetically engineered animals, Kidney Int, 68, 925, 10.1111/j.1523-1755.2005.00486.x

Han, 2009, CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages, Cardiovasc Res, 84, 378, 10.1093/cvr/cvp240

Brosius, 2009, Mouse models of diabetic nephropathy, J Am Soc Nephrol, 20, 2503, 10.1681/ASN.2009070721

Le, 2004, Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency, Hypertension, 43, 445, 10.1161/01.HYP.0000112423.28987.00

Chorvat, 2013, Peripherally restricted CB1 receptor blockers, Bioorg Med Chem Lett, 23, 4751, 10.1016/j.bmcl.2013.06.066

Marquart, 2010, Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis, Arthritis Rheum, 62, 3467, 10.1002/art.27642

Teixeira-Clerc, 2006, CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis, Nat Med, 12, 671, 10.1038/nm1421

Slavic, 2013, Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome, J Mol Med Berl Ger, 91, 811, 10.1007/s00109-013-1034-0

André, 2010, The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment, Int J Biochem Cell Biol, 42, 1788, 10.1016/j.biocel.2010.06.002

Nam, 2012, Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice, Endocrinology, 153, 1387, 10.1210/en.2011-1423

Defer, 2009, The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy, FASEB J Off Publ Fed Am Soc Exp Biol, 23, 2120

Servettaz, 2010, Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis, Am J Pathol, 177, 187, 10.2353/ajpath.2010.090763

Barutta, 2011, Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy, Diabetes, 60, 2386, 10.2337/db10-1809

Barutta, 2014, Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice, Kidney Int [Internet], 86, 979, 10.1038/ki.2014.165

Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J Clin Invest, 117, 524, 10.1172/JCI31487

Sato, 2003, Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, J Clin Invest., 112, 1486, 10.1172/JCI200319270

Eis, 2004, Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction, J Am Soc Nephrol, 15, 337, 10.1097/01.ASN.0000111246.87175.32

Henderson, 2008, Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis, Am J Pathol, 172, 288, 10.2353/ajpath.2008.070726

Schatz, 1997, Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system, Toxicol Appl Pharmacol, 142, 278, 10.1006/taap.1996.8034

Wang, 2011, Macrophages in renal disease, J Am Soc Nephrol, 22, 21, 10.1681/ASN.2010030269

Wang, 2009, Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension, Am J Physiol Renal Physiol, 297, F1550, 10.1152/ajprenal.00012.2009

Ledent, 1999, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice, Science, 283, 401, 10.1126/science.283.5400.401

Grimwood, 2009, Propagation and culture of renal fibroblasts, Methods Mol Biol, 466, 25, 10.1007/978-1-59745-352-3_3